Progress in Cardiovascular Diseases
Volume 53, Issue 2 , Pages 157-163 , September 2010

Evaluation and Management of Pericardial Effusion in Patients with Neoplastic Disease

  • Bernhard Maisch

      Affiliations

    • Department of Internal Medicine and Cardiology, UKGM GmbH Gießen and Marburg, Marburg Heart Center and Faculty of Medicine, Philipps-University, Marburg, Germany
    • Corresponding Author InformationAddress reprint requests to Bernhard Maisch, FESC, FACC, Baldingerstr., 35043 Marburg, Germany.
    • ,
  • Arsen Ristic

      Affiliations

    • Department of Cardiology, Belgrade University, Belgrade, Serbia
    • ,
  • Sabine Pankuweit

      Affiliations

    • Department of Internal Medicine and Cardiology, UKGM GmbH Gießen and Marburg, Marburg Heart Center and Faculty of Medicine, Philipps-University, Marburg, Germany

References 

  1. Mukai K, Shinkai T, Tominaga K, et al. The incidence of secondary tumours of the heart and pericardium: a 10 year study. Jpn J Clin Oncol. 1988;18:195–201
  2. Posner MR, Cohen GI, Skarin AT. Pericardial disease in patients with cancer. Am J Med. 1981;71:407–413
  3. Wilding G, Green HL, Longo DL, et al. Tumours of the heart and pericardium. Cancer Treat Rev. 1988;15:165–181
  4. Maisch B, Ristic AD, Seferovic PM, et al. Interventional pericardiology-pericardiocentesis, pericardioscopy, pericardial biopsy, balloon pericardiotomy and intrapericardial therapy. Berlin: Springer Heidelberg; 2010;[With contributions from S Pankuweit, R Maksimovic, H Rupp, JK Oh, JB Seward and AJ Tajik]
  5. Maisch B, Seferovic PM, Ristic AD, et al. Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Guidelines in the diagnosis and management of pericardial diseases. Eur Heart J. 2004;25:587–610
  6. Maisch B, Ristić AD, Pankuweit S. Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone: the way to avoid side effects of systemic corticosteroid therapy. Eur Heart J. 2002;23:1503–1508
  7. Maisch B, Ristić AD, Pankuweit S, et al. Neoplastic pericardial effusion: efficacy and safety of intrapericardial treatment with cisplatin. Eur Heart J. 2002;23:1625–1631
  8. Spodick DH. Pericardial diseases. In:  Braunwald E,  Zipes DP,  Libby P editor. Heart disease. 6th ed.. Philadelphia, PA: W.B. Saunders; 2001;p. 1823–1876
  9. Ziskind AA, Palacios IF. Percutaneous balloon pericardiotomy for patients with pericardial effusion and tamponade. In:  Topol EJ editors. Textbook of interventional cardiology. 3rd Ed. Philadelphia, PA: W.B. Saunders Co.; 1999;p. 869–877
  10. Ristić AD, Seferović PM, Maksimović R, et al. Percutaneous balloon pericardiotomy in neoplastic pericardial effusion. In:  Seferović PM,  Spodick DH,  Maisch B,  Maksimović R,  Ristić AD editor. Pericardiology: contemporary answers to continuing challenges. Belgrade: Science; 2000;p. 427–438
  11. Maisch B, Pankuweit S, Brilla C, et al. Intrapericardial treatment of inflammatory and neoplastic pericarditis guided by pericardioscopy and epicardial biopsy—results from a pilot study. Clin Cardiol. 1999;22(Suppl 1):I17–22
  12. Aitini E, Cavazzini G, Pasquini E, et al. Treatment of primary or metastatic pleural effusion with intracavitary cytosine arabinoside and cisplatin. A phase II study. Acta Oncol. 1994;33:191–194
  13. Bindi M, Trusso M, Tucci E. Intracavitary cisplatin in malignant cardiac tamponade. Tumori. 1987;73:163–165
  14. Pavon-Jimenez R, Garcia-Rubira JC, Garcia-Martinez JT, et al. Intrapericardial cisplatin for malignant tamponade. Rev Esp Cardiol. 2000;53:587–589
  15. Tomkowski W, Szturmowicz M, Fijalkowska A, et al. Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion. J Cancer Res Clin Oncol. 1994;120:434–436
  16. Tomkowski WZ, Filipecki S. Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion in the course of the lung cancer. Lung Cancer. 1997;16:215–222
  17. Tomkowski WZ, Filipecki S. Intrapericardial administration of cisplatin in treatment of metastatic pericardial involvement in adenocarcinoma of the lung. Arch Chest Dis. 1997;52:221–224
  18. Tomkowski W, Szturmowicz M, Fijalkowska A, et al. New approaches to the management and treatment of malignant pericardial effusion. Support Care Cancer. 1997;5:64–66
  19. Fiorentino MV, Daniele O, Morandi P, et al. Intrapericardial instillation of platin in malignant pericardial effusion. Cancer. 1988;62:1904–1906
  20. Tondini M, Rocco G, Bianchi C, et al. Intracavitary cisplatin (CDDP) in the treatment of metastatic pericardial involvement from breast and lung cancer. Monaldi Arch Chest Dis. 1995;50:86–88
  21. Lestuzzi Ch, Viel E, Sorio R, et al. Local chemotherapy for neoplastic pericardial effusion [letter]. Am J Cardiol. 2000;86:1292
  22. Beretta F, Martinelli G, Cavalli F, et al. Pericardial effusion in patients with malignant neoplasms. Schweiz Med Wochenschr. 1992;122:1517–1524
  23. Bishiniotis TS, Antoniadou S, Katseas G, et al. Malignant cardiac tamponade in women with breast cancer treated by pericardiocentesis and intrapericardial administration of triethylenethiophosphoramide (thiotepa). Am J Cardiol. 2000;86:362–364
  24. Colleoni M, Martinelli G, Beretta F, et al. Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimen. J Clin Oncol. 1998;16:2371–2376
  25. Girardi LN, Ginsberg RJ, Burt ME. Pericardiocentesis and intrapericardial sclerosis: effective therapy for malignant pericardial effusions. Ann Thorac Surg. 1997;64:1422–1427
  26. Martinoni A, Cipolla CM, Civelli M, et al. Intrapericardial treatment of neoplastic pericardial effusions. Herz. 2000;25:787–793
  27. Fukuoka M, Takada M, Tamai S, et al. Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion. Gan To Kagaku Ryoho. 1984;11:1543–1549
  28. Lee LN, Yang PC, Chang DB, et al. Ultrasound guided pericardial drainage and intrapericardial instillation of mitomycin C for malignant pericardial effusion. Thorax. 1994;49:594–595
  29. Liu G, Crump M, Goss PE, et al. Prospective comparison of the sclerosing agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponade. J Clin Oncol. 1996;14:3141–3147
  30. van der Gaast A, Kok TC, van der Linden NH, et al. Intrapericardial instillation of bleomycin in the management of malignant pericardial effusion. Eur J Cancer Clin Oncol. 1989;25:1505–1506
  31. Yano T, Yokoyama H, Inoue T, et al. A simple technique to manage malignant pericardial effusion with a local instillation of bleomycin in non-small cell carcinoma of the lung. Oncology. 1994;51:507–509
  32. Cormican MC, Nyman CR. Intrapericardial bleomycin for the management of cardiac tamponade secondary to malignant pericardial effusion. Br Heart J. 1990;63:61–62
  33. Davis S, Rambotti P, Grignani F. Intrapericardial tetracycline sclerosis in the treatment of malignant pericardial effusion: an analysis of thirty-three cases. J Clin Oncol. 1984;2:631–636
  34. Maher EA, Shepherd FA, Todd TJ. Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade. J Thorac Cardiovasc Surg. 1996;112:637–643
  35. Salamon P, Berliner S, Shachner A, et al. Tetracycline treatment for malignant pericardial effusion. Med Interne. 1989;27:73–74
  36. Shepherd FA, Ginsberg JS, Evans WK, et al. Tetracycline sclerosis in the management of malignant pericardial effusion. J Clin Oncol. 1985;3:1678–1682
  37. Shepherd FA, Morgan C, Evans WK, et al. Medical management of malignant pericardial effusion by tetracycline sclerosis. Am J Cardiol. 1987;60:1161–1166
  38. Norum J, Lunde P, Aasebo U, et al. Mitoxantrone in malignant pericardial effusion. J Chemother. 1998;10:399–404
  39. Primrose WR, Clee MD, Johnston RN. Malignant pericardial effusion managed with Vinblastine. Clin Oncol. 1983;9:67–70
  40. Dempke W, Firusian N. Treatment of malignant pericardial effusion with 32P-colloid. Br J Cancer. 1999;80:1955–1957
  41. Firusian N. 32P therapy of malignant pericardial effusions. Onkologie. 1980;3:12–17
  42. Martini N, Freiman AH, Watson RC, et al. Intrapericardial installation of radioactive chromic phosphate in malignant effusion. AJR Am J Roentgenol. 1977;128:639–641
  43. Sprengelmeyer JT, McDermott RL. Phosphorus-32-colloidal chromic phosphate: treatment of choice for malignant pericardial effusion. J Nucl Med. 1990;31:2034–2036
  44. Lissoni P, Barni S, Tancini G, et al. Intracavitary therapy of neoplastic effusions with cytokines: comparison among interferon alpha, beta and interleukin-2. Support Care Cancer. 1995;3:78–80
  45. Imamura T, Tamura K, Takenaga M, et al. Intrapericardial OK-432 instillation for the management of malignant pericardial effusion. Cancer. 1991;68:259–263
  46. Keane D, Jackson G. Managing recurrent malignant pericardial effusions. Br Med J. 1992;305:729–730
  47. Tulleken JE, Kooiman CG, van der Werf TS, et al. Constrictive pericarditis after high-dose chemotherapy. Lancet. 1997;350:1601
  48. Kahles H, Bastian HJ, Schiffmann O, et al. Mitoxantrone-induced acute left heart failure after intrapleural administration. Herz. 1997;22:217–220
  49. Seferović PM, Ristić AD, Maksimović R, et al. Treatment of neoplastic pericardial effusion: percutaneous balloon pericardiotomy vs. prolonged subxiphoid drainage [abstract]. Eur Heart J. 2000;21(Suppl. August/September):418

 Statement of Conflict of Interest: see page 162.

PII: S0033-0620(10)00108-8

doi: 10.1016/j.pcad.2010.06.003

Progress in Cardiovascular Diseases
Volume 53, Issue 2 , Pages 157-163 , September 2010

Article Tools

* Image Usage & Resolution